Trademarkia Logo

Canada

C$
SOLVETX
ADVERTISED

on 1 Jan 2025

Last Applicant/ Owned by

Solve Therapeutics, Inc.

11045 Roselle St., Suite 130San Diego CA 92121

US

Serial Number

2204863 filed on 22nd Jul 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

550 BURRARD STREETSUITE 2300VANCOUVER

BRITISH COLUMBIA

CA

V6C2B5

SOLVETX

Trademark usage description

pharmaceutical preparations and biological preparations for the treatment of oncological diseases and disorders, autoimmune diseases and disorders, an Read More

Classification Information


Class [005]
Pharmaceutical preparations and biological preparations for the treatment of oncological diseases and disorders, autoimmune diseases and disorders, and treatment of hematologic and solid tumor cancers; diagnostic preparations for medical use, namely, biological diagnostic preparations for medical use for diagnosing oncological diseases and disorders, autoimmune diseases and disorders, and hematologic and solid tumor cancers.


Classification kind code

11

Mark Details


Serial Number

2204863

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 22nd May 2024
Agent Changed
Submitted for opposition 22
on 27th Nov 2023
Search Recorded
Submitted for opposition 20
on 27th Nov 2023
Examiner's First Report
Submitted for opposition 223
on 27th Nov 2023
Total Provisional Refusal
Submitted for opposition 256
on 19th Jun 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 18th Aug 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 17th Aug 2022
Created
Submitted for opposition 31
on 17th Aug 2022
Formalized
Submitted for opposition 30
on 22nd Jul 2022
Filed
Submitted for opposition 228
on 22nd Jul 2022
International Registration